- call +1-201-465-4211
- email sales@mrinsights.biz
Ophthalmoplegia refers to weakness (-paresis) or paralysis (-plegia) of one or more extraocular muscleswhich are responsible for eye movements. It is a physical finding in certain neurologic, ophthalmologic, and endocrine disease. Internal ophthalmoplegia means involvement limited to the pupillary sphincter and ciliary muscle. External ophthalmoplegia refers to involvement of only the extraocular muscles. Complete ophthalmoplegia indicates involvement of both.
Scope of the Report:
This report studies the Ophthalmoplegia market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Ophthalmoplegia market by product type and applications/end industries.
Ophthalmoparesis can involve any or all of the extraocular muscles, which include the superior recti, inferior recti, medial recti, lateral recti, inferior oblique and superior oblique muscles. Treatment and prognosis depend on the underlying condition. For example, in thiamine deficiency, treatment would be the immediate administration of vitamin B1.
The global Ophthalmoplegia market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Ophthalmoplegia.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Abbott
Novartis
Zeiss
Valeant Pharmaceuticals
Amritt
Medline Industries
Allergan
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
External Ophthalmoplegia
Internuclear Opthalmoplegia
Market Segment by Applications, can be divided into
Hospital & Clinics
Ambulatory Clinics
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Ophthalmoplegia Market Overview
1.1 Product Overview and Scope of Ophthalmoplegia
1.2 Classification of Ophthalmoplegia by Types
1.2.1 Global Ophthalmoplegia Revenue Comparison by Types (2017-2023)
1.2.2 Global Ophthalmoplegia Revenue Market Share by Types in 2017
1.2.3 External Ophthalmoplegia
1.2.4 Internuclear Opthalmoplegia
1.3 Global Ophthalmoplegia Market by Application
1.3.1 Global Ophthalmoplegia Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital & Clinics
1.3.3 Ambulatory Clinics
1.4 Global Ophthalmoplegia Market by Regions
1.4.1 Global Ophthalmoplegia Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Ophthalmoplegia Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Ophthalmoplegia Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Ophthalmoplegia Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Ophthalmoplegia Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Ophthalmoplegia Status and Prospect (2013-2023)
1.5 Global Market Size of Ophthalmoplegia (2013-2023)
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Business Overview
2.1.2 Ophthalmoplegia Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Ophthalmoplegia Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Ophthalmoplegia Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Ophthalmoplegia Revenue, Gross Margin and Market Share (2016-2017)
2.3 Zeiss
2.3.1 Business Overview
2.3.2 Ophthalmoplegia Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Zeiss Ophthalmoplegia Revenue, Gross Margin and Market Share (2016-2017)
2.4 Valeant Pharmaceuticals
2.4.1 Business Overview
2.4.2 Ophthalmoplegia Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Valeant Pharmaceuticals Ophthalmoplegia Revenue, Gross Margin and Market Share (2016-2017)
2.5 Amritt
2.5.1 Business Overview
2.5.2 Ophthalmoplegia Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Amritt Ophthalmoplegia Revenue, Gross Margin and Market Share (2016-2017)
2.6 Medline Industries
2.6.1 Business Overview
2.6.2 Ophthalmoplegia Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Medline Industries Ophthalmoplegia Revenue, Gross Margin and Market Share (2016-2017)
2.7 Allergan
2.7.1 Business Overview
2.7.2 Ophthalmoplegia Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Allergan Ophthalmoplegia Revenue, Gross Margin and Market Share (2016-2017)
3 Global Ophthalmoplegia Market Competition, by Players
3.1 Global Ophthalmoplegia Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Ophthalmoplegia Players Market Share
3.2.2 Top 10 Ophthalmoplegia Players Market Share
3.3 Market Competition Trend
4 Global Ophthalmoplegia Market Size by Regions
4.1 Global Ophthalmoplegia Revenue and Market Share by Regions
4.2 North America Ophthalmoplegia Revenue and Growth Rate (2013-2018)
4.3 Europe Ophthalmoplegia Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Ophthalmoplegia Revenue and Growth Rate (2013-2018)
4.5 South America Ophthalmoplegia Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Ophthalmoplegia Revenue and Growth Rate (2013-2018)
5 North America Ophthalmoplegia Revenue by Countries
5.1 North America Ophthalmoplegia Revenue by Countries (2013-2018)
5.2 USA Ophthalmoplegia Revenue and Growth Rate (2013-2018)
5.3 Canada Ophthalmoplegia Revenue and Growth Rate (2013-2018)
5.4 Mexico Ophthalmoplegia Revenue and Growth Rate (2013-2018)
6 Europe Ophthalmoplegia Revenue by Countries
6.1 Europe Ophthalmoplegia Revenue by Countries (2013-2018)
6.2 Germany Ophthalmoplegia Revenue and Growth Rate (2013-2018)
6.3 UK Ophthalmoplegia Revenue and Growth Rate (2013-2018)
6.4 France Ophthalmoplegia Revenue and Growth Rate (2013-2018)
6.5 Russia Ophthalmoplegia Revenue and Growth Rate (2013-2018)
6.6 Italy Ophthalmoplegia Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Ophthalmoplegia Revenue by Countries
7.1 Asia-Pacific Ophthalmoplegia Revenue by Countries (2013-2018)
7.2 China Ophthalmoplegia Revenue and Growth Rate (2013-2018)
7.3 Japan Ophthalmoplegia Revenue and Growth Rate (2013-2018)
7.4 Korea Ophthalmoplegia Revenue and Growth Rate (2013-2018)
7.5 India Ophthalmoplegia Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Ophthalmoplegia Revenue and Growth Rate (2013-2018)
8 South America Ophthalmoplegia Revenue by Countries
8.1 South America Ophthalmoplegia Revenue by Countries (2013-2018)
8.2 Brazil Ophthalmoplegia Revenue and Growth Rate (2013-2018)
8.3 Argentina Ophthalmoplegia Revenue and Growth Rate (2013-2018)
8.4 Colombia Ophthalmoplegia Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Ophthalmoplegia by Countries
9.1 Middle East and Africa Ophthalmoplegia Revenue by Countries (2013-2018)
9.2 Saudi Arabia Ophthalmoplegia Revenue and Growth Rate (2013-2018)
9.3 UAE Ophthalmoplegia Revenue and Growth Rate (2013-2018)
9.4 Egypt Ophthalmoplegia Revenue and Growth Rate (2013-2018)
9.5 Nigeria Ophthalmoplegia Revenue and Growth Rate (2013-2018)
9.6 South Africa Ophthalmoplegia Revenue and Growth Rate (2013-2018)
10 Global Ophthalmoplegia Market Segment by Type
10.1 Global Ophthalmoplegia Revenue and Market Share by Type (2013-2018)
10.2 Global Ophthalmoplegia Market Forecast by Type (2018-2023)
10.3 External Ophthalmoplegia Revenue Growth Rate (2013-2023)
10.4 Internuclear Opthalmoplegia Revenue Growth Rate (2013-2023)
11 Global Ophthalmoplegia Market Segment by Application
11.1 Global Ophthalmoplegia Revenue Market Share by Application (2013-2018)
11.2 Ophthalmoplegia Market Forecast by Application (2018-2023)
11.3 Hospital & Clinics Revenue Growth (2013-2018)
11.4 Ambulatory Clinics Revenue Growth (2013-2018)
12 Global Ophthalmoplegia Market Size Forecast (2018-2023)
12.1 Global Ophthalmoplegia Market Size Forecast (2018-2023)
12.2 Global Ophthalmoplegia Market Forecast by Regions (2018-2023)
12.3 North America Ophthalmoplegia Revenue Market Forecast (2018-2023)
12.4 Europe Ophthalmoplegia Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Ophthalmoplegia Revenue Market Forecast (2018-2023)
12.6 South America Ophthalmoplegia Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Ophthalmoplegia Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Ophthalmoplegia Picture
Table Product Specifications of Ophthalmoplegia
Table Global Ophthalmoplegia and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
